Cessatech
19.12 DKK
-6.04 %
Less than 1K followers
CESSA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-6.04 %
-0.10 %
+19.80 %
+60.40 %
+71.33 %
+69.20 %
+1,034.72 %
+17.86 %
+77.29 %
Cessatech is a pivotal-stage paediatric biotech company developing first-in-class specialty hospital medicines for children, focused on high-impact unmet needs in acute and emergency care. The company focuses on specialty products designed for use in clinical settings and advances its programs through a partnership-based development model. Founded in 2020, Cessatech is headquartered in Denmark and led by a team with experience across drug development and commercialization.
Read moreMarket cap
355.18M DKK
Turnover
1.11M DKK
Revenue
2.49M
EBIT %
-765.06 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27.2
2026
Annual report '25
30.3
2026
General meeting '26
28.5
2026
Interim report Q1'26
All
Research
Press releases
ShowingAll content types
Cessatech: Third Quarter Report Q3-2025
Cessatech: CT001 soon available for US hospitals in collaboration with STAQ Pharma, for acute pain management in children
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools